Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6086700rdf:typepubmed:Citationlld:pubmed
pubmed-article:6086700lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0010132lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0001655lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0008810lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0011777lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0033195lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:6086700lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:6086700pubmed:issue3lld:pubmed
pubmed-article:6086700pubmed:dateCreated1984-9-18lld:pubmed
pubmed-article:6086700pubmed:abstractTextThe circadian rhythm, suppression with dexamethasone, and stimulation by corticotropin-releasing hormone (CRH) of plasma immunoreactive (IR) proopiomelanocortin N-terminal (NT) and IR-ACTH were studied in nine normal subjects and two patients with Addison's disease. The RIA for human NT (hNT) used was specific for NT except for partial cross-reactivity with gamma 2MSH. In normal subjects, plasma IR-hNT and IR-ACTH had almost parallel circadian rhythms and were suppressed by dexamethasone. The mean plasma levels of IR-hNT and IR-ACTH at 0800 h were 140 +/- 23 (SD) and 23 +/- 5 pg/ml, respectively. Plasma IR-hNT increased in parallel with IR-ACTH 15 to 30 min after iv injection of 100 micrograms ovine CRH. Maximum percent increases in plasma IR-hNT and IR-ACTH were 185 +/- 47 and 235 +/- 10%, respectively. In Addison's disease, on the other hand, plasma levels of IR-hNT and IR-ACTH were markedly elevated and the circadian rhythms were parallel. The mean plasma IR-hNT and IR-ACTH levels at 0900 h were 4363 and 1750 pg/ml, respectively. These results suggest that plasma hNT and ACTH are produced from a common precursor in the pituitary gland and secreted concomitantly under various physiological conditions such as stimulation by CRH and inhibition by glucocorticoid.lld:pubmed
pubmed-article:6086700pubmed:languageenglld:pubmed
pubmed-article:6086700pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6086700pubmed:statusMEDLINElld:pubmed
pubmed-article:6086700pubmed:monthSeplld:pubmed
pubmed-article:6086700pubmed:issn0021-972Xlld:pubmed
pubmed-article:6086700pubmed:authorpubmed-author:TakahashiHHlld:pubmed
pubmed-article:6086700pubmed:authorpubmed-author:IbayashiHHlld:pubmed
pubmed-article:6086700pubmed:authorpubmed-author:MotomatsuTTlld:pubmed
pubmed-article:6086700pubmed:authorpubmed-author:NobunagaMMlld:pubmed
pubmed-article:6086700pubmed:issnTypePrintlld:pubmed
pubmed-article:6086700pubmed:volume59lld:pubmed
pubmed-article:6086700pubmed:ownerNLMlld:pubmed
pubmed-article:6086700pubmed:authorsCompleteYlld:pubmed
pubmed-article:6086700pubmed:pagination495-8lld:pubmed
pubmed-article:6086700pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:meshHeadingpubmed-meshheading:6086700-...lld:pubmed
pubmed-article:6086700pubmed:year1984lld:pubmed
pubmed-article:6086700pubmed:articleTitleHuman plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.lld:pubmed
pubmed-article:6086700pubmed:publicationTypeJournal Articlelld:pubmed